Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients

被引:9
作者
Barbe, Anna Greta [1 ]
Ludwar, Lena [1 ]
Scharfenberg, Isabel [1 ]
Hellmich, Martin [2 ]
Dano, Richard [3 ]
Barbe, Michael Thomas [3 ]
Noack, Michael Johannes [1 ]
机构
[1] Univ Cologne, Dept Operat Dent & Periodontol, Ctr Dent Med, Kerpener Str 32, D-50931 Cologne, Germany
[2] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany
[3] Univ Cologne, Dept Neurol, Cologne, Germany
关键词
dopamine agonists; dry mouth; hypersialorrhea; nonmotor symptoms; Parkinson's disease; swallowing disorder; QUALITY-OF-LIFE; L-DOPA; DYSPHAGIA; RADIOTHERAPY; DYSFUNCTION; SYMPTOMS; IMPACT; SAMPLE;
D O I
10.1111/odi.12942
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives Parkinson's disease (PD) patients suffer from xerostomia, but limited information exists regarding associations with dysphagia, drooling, daily habits, PD characteristics, or possible circadian rhythms. Subjects and methods A questionnaire was administered, including (a) clinical characteristics (comorbidities, prescribed medications, levodopa equivalent daily dose [LEDD], disease duration); (b) self-assessment of dysphagia, xerostomia, drooling (10-cm visual analogue scale [VAS]); (c) 24-hr diary of motor impairment, dyskinesia, xerostomia, dysphagia, drooling, daily habits. Results Of 75 PD patients who completed the study, 67% reported dysphagia (mean +/- standard deviation VAS 4 +/- 2), 76% drooling (5 +/- 2), 77% xerostomia (5 +/- 2). Xerostomia was associated with comorbidities (p = 0.021) and smoking (p = 0.010) and affected by tremor (p = 0.003), dyskinesia (p = 0.010), dysphagia (p < 0.001), food intake (p = 0.005), sleep (p = 0.011), age (p = 0.018), medication intake (p = 0.063), LEDD (p = 0.052), daytime (p = 0.075), disease duration (p = 0.004). Xerostomia peaked at 9 a.m. and 9 p.m. Conclusions PD patients suffer from xerostomia, dysphagia, and drooling. Subjective dysphagia is associated with drooling and xerostomia, but drooling prevalence or intensity does not influence xerostomia symptoms. Tremor, dyskinesia, and disease duration, which characterise PD, affect xerostomia. Additionally, food intake, sleep, age, LEDD, and daytime (peaks at 9 a.m. and 9 p.m.) increase xerostomia occurrence. This knowledge may improve dentists' advice to patients and aid development of patient-centred, symptom-relieving products.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 45 条
  • [1] Hyposalivation and xerostomia among Parkinson's disease patients and its impact on quality of life
    Barbe, A. G.
    Heinzler, A.
    Derman, S. H. M.
    Hellmich, M.
    Timmermann, L.
    Noack, M. J.
    [J]. ORAL DISEASES, 2017, 23 (04) : 464 - 470
  • [2] Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson's disease patients
    Barbe, Anna Greta
    Bock, Nadine
    Derman, Sonja Henny Maria
    Felsch, Moritz
    Timmermann, Lars
    Noack, Michael Johannes
    [J]. GERODONTOLOGY, 2017, 34 (01) : 135 - 143
  • [3] BIANCHINE J R, 1976, Clinical Pharmacokinetics, V1, P313, DOI 10.2165/00003088-197601050-00001
  • [4] The challenge of non-motor symptoms in Parkinson's disease
    Bjorklund, Anders
    Cenci, M. Angela
    [J]. RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : 325 - 341
  • [5] Dry Mouth: An Overlooked Autonomic Symptom of Parkinson's Disease
    Cersosimo, Maria G.
    Raina, Gabriela B.
    Calandra, Cristian R.
    Pellene, Alejandro
    Gutierrez, Cristiam
    Micheli, Federico E.
    Benarroch, Eduardo E.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2011, 1 (02) : 169 - 173
  • [6] CIRCADIAN-RHYTHMS IN HUMAN SALIVARY FLOW-RATE AND COMPOSITION
    DAWES, C
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1972, 220 (03): : 529 - &
  • [7] Delli K, 2014, MONOGR ORAL SCI, V24, P109, DOI 10.1159/000358792
  • [8] The influence of xerostomia after radiotherapy on quality of life
    Dirix, Piet
    Nuyts, Sandra
    Poorten, Vincent Vander
    Delaere, Pierre
    Van den Bogaert, Walter
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (02) : 171 - 179
  • [9] Pramipexole - A review of its use in the management of early and advanced Parkinson's disease
    Dooley, M
    Markham, A
    [J]. DRUGS & AGING, 1998, 12 (06) : 495 - 514
  • [10] The Parkinson Pandemic-A Call to Action
    Dorsey, E. Ray
    Bloem, Bastiaan R.
    [J]. JAMA NEUROLOGY, 2018, 75 (01) : 9 - 10